Watermark
  Back to Search Results

BGB-A317-B167-101

Terminated

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-B167-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05494762

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents